179 related articles for article (PubMed ID: 10490821)
1. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
[TBL] [Abstract][Full Text] [Related]
2. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
3. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
5. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K
Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
8. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
[TBL] [Abstract][Full Text] [Related]
9. Mad-related genes in the human.
Riggins GJ; Thiagalingam S; Rozenblum E; Weinstein CL; Kern SE; Hamilton SR; Willson JK; Markowitz SD; Kinzler KW; Vogelstein B
Nat Genet; 1996 Jul; 13(3):347-9. PubMed ID: 8673135
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
11. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4.
Morén A; Itoh S; Moustakas A; Dijke P; Heldin CH
Oncogene; 2000 Sep; 19(38):4396-404. PubMed ID: 10980615
[TBL] [Abstract][Full Text] [Related]
12. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
[TBL] [Abstract][Full Text] [Related]
13. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
[TBL] [Abstract][Full Text] [Related]
14. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
15. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma.
Kawate S; Ohwada S; Hamada K; Koyama T; Takenoshita S; Morishita Y; Hagiwara K
Int J Mol Med; 2001 Jul; 8(1):49-52. PubMed ID: 11408948
[TBL] [Abstract][Full Text] [Related]
18. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
19. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
20. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
Hummer BT; Bartlett C; Henry E; Weissman BE
J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
